ALK is a research-driven global pharmaceutical company focusing on allergy prevention, diagnosis and treatment. ALK is a world leader in allergy immunotherapy — a treatment of the underlying cause of allergy. The company has approximately 1,800 employees with subsidiaries, production facilities and distributors worldwide.
The company is headquartered in Hørsholm, Denmark, and listed on NASDAQ Copenhagen.
Contact
Transistorstraat 23-25
1322 CK Almere
The Netherlands
Tel: +31 (0)36 539 7724
Web: alk.net/nl
See our Cookie Privacy Policy Here
